The upcoming Health & Wellness Global Alliance’s Dermatology CME Conference will address the global burden of eczema.
The inaugural conference is slated to be held November 13-16, 2025, at The Sanctuary, Kiawah Island, SC, and will feature an international perspective on diagnosis and management of eczema, as well as a broad range of other dermatologic conditions. Beyond pharmacological advancements, the discussions will also focus on issues like supportive skincare, environmental exposures, the microbiome, and more.
“The evidence is clear. The impact of eczema can be substantial, and it is imperative that dermatologists implement effective treatments appropriate to the severity of the presentation,” says Conference Founder Firas George Hougeir, MD, FAAD, in a news release. “Across the US and around the world, patients and their families struggle with intense itch, excoriations, pain, and sleep disruptions. Thankfully, we in the United States have effective new topical and systemic treatments to support our patients. Globally, a number of investigational treatments show promise and could make their way to us and our patients.”
“Eczema is common, and even though we see it in dermatology clinics every day, we continue to learn more about the disease,” notes Conference Founder Jonathan Weiss, MD, FAAD. “In just the past few years, we have come to better understand the pathogenesis of eczema and have seen approval of new treatments that target critical pathways. This allows us to treat eczema more efficiently and with favorable safety compared to many of the treatments we used traditionally.”
